» Articles » PMID: 30733298

Infiltration of CD8 T Cells into Tumor Cell Clusters in Triple-negative Breast Cancer

Overview
Specialty Science
Date 2019 Feb 9
PMID 30733298
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Infiltration of [Formula: see text] T lymphocytes into solid tumors is associated with good prognosis in various types of cancer, including triple-negative breast cancer (TNBC). However, the mechanisms underlying different infiltration levels are largely unknown. Here, we have characterized the spatial profile of [Formula: see text] T cells around tumor cell clusters (tightly connected tumor cells) in the core and margin regions in TNBC patient samples. We found that in some patients, the [Formula: see text] T cell density first decreases when moving in from the boundary of the tumor cell clusters and then rises again when approaching the center. To explain various infiltration profiles, we modeled the dynamics of T cell density via partial differential equations. We spatially modulated the diffusion/chemotactic coefficients of T cells (to mimic physical barriers) or introduced the localized secretion of a diffusing T cell chemorepellent. Combining the spatial-profile analysis and the modeling led to support for the second idea; i.e., there exists a possible chemorepellent inside tumor cell clusters, which prevents [Formula: see text] T cells from infiltrating into tumor cell clusters. This conclusion was consistent with an investigation into the properties of collagen fibers which suggested that variations in desmoplastic elements does not limit infiltration of [Formula: see text] T lymphocytes, as we did not observe significant correlations between the level of T cell infiltration and fiber properties. Our work provides evidence that [Formula: see text] T cells can cross typical fibrotic barriers and thus their infiltration into tumor clusters is governed by other mechanisms possibly involving a local repellent.

Citing Articles

Unraveling microglial spatial organization in the developing human brain with DeepCellMap, a deep learning approach coupled with spatial statistics.

Perochon T, Krsnik Z, Massimo M, Ruchiy Y, Romero A, Mohammadi E Nat Commun. 2025; 16(1):1577.

PMID: 39948387 PMC: 11825940. DOI: 10.1038/s41467-025-56560-z.


Understanding the interplay between extracellular matrix topology and tumor-immune interactions: Challenges and opportunities.

Fan Y, Chiu A, Zhao F, George J Oncotarget. 2024; 15:768-781.

PMID: 39513932 PMC: 11546212. DOI: 10.18632/oncotarget.28666.


Targeting CD93 on monocytes revitalizes antitumor immunity by enhancing the function and infiltration of CD8 T cells.

Jiang D, Huang A, Zhu B, Gong J, Ruan Y, Liu X J Immunother Cancer. 2024; 12(10).

PMID: 39448202 PMC: 11499807. DOI: 10.1136/jitc-2024-010148.


Spatiotemporal dynamics of tumor - CAR T-cell interaction following local administration in solid cancers.

Owens K, Rahman A, Bozic I bioRxiv. 2024; .

PMID: 39257746 PMC: 11384001. DOI: 10.1101/2024.08.29.610392.


CD8 T cell‑related KCTD5 contributes to malignant progression and unfavorable clinical outcome of patients with triple‑negative breast cancer.

Li J, Yao J Mol Med Rep. 2024; 30(3).

PMID: 39027992 PMC: 11267436. DOI: 10.3892/mmr.2024.13290.


References
1.
Sato E, Olson S, Ahn J, Bundy B, Nishikawa H, Qian F . Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A. 2005; 102(51):18538-43. PMC: 1311741. DOI: 10.1073/pnas.0509182102. View

2.
Verdegaal E, Hoogstraten C, Sandel M, Kuppen P, Brink A, Claas F . Functional CD8+ T cells infiltrate into nonsmall cell lung carcinoma. Cancer Immunol Immunother. 2006; 56(5):587-600. PMC: 11030057. DOI: 10.1007/s00262-006-0214-y. View

3.
Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C . Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006; 313(5795):1960-4. DOI: 10.1126/science.1129139. View

4.
Sharma P, Shen Y, Wen S, Yamada S, Jungbluth A, Gnjatic S . CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma. Proc Natl Acad Sci U S A. 2007; 104(10):3967-72. PMC: 1820692. DOI: 10.1073/pnas.0611618104. View

5.
Clark W . Tumour progression and the nature of cancer. Br J Cancer. 1991; 64(4):631-44. PMC: 1977704. DOI: 10.1038/bjc.1991.375. View